Starpharma Holdings Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other companies in this sector in AUSTRALIA : Terragen Holdings Ltd (2021 sales of 3.98 million Australian Dollars [US$2.88 million] of which 100% was Biological Products), PYC Therapeutics Ltd (3.08 million Australian Dollars [US$2.23 million] ), and Hexima Ltd (4.08 million Australian Dollars [US$2.96 million] of which 100% was Biotechnology & Medical Research).

Sales Analysis. During the year ended June of 2021, sales at Starpharma Holdings Limited were A$3.49 million (US$2.53 million). This is a sharp decrease of 51.0% versus 2020, when the company's sales were A$7.12 million.